SCHEMBL2568491

SCHEMBL2568491

CN1CCc2ccc(NC(=O)OC3(NC(=O)c4ccc(Cl)s4)CCOC3)cc2CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR91 A4D1P6 1/20 0.40
KMT2A Q03164 4/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
F10 P00742 15/20 0.38
NPC1 O15118 2/20 0.37
NFKB1 P19838 2/20 0.37
RAB9A P51151 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2571140 0.95 KMT2A (0.41) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2571235 0.91 WDR91 (0.38) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL3379487 0.91 WDR91 (0.38) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2569492 0.91 F10 (0.35) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2565621 0.90 KMT2A (0.44) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2569660 0.90 MEN1 (0.48) WDR91KMT2AMAPK1MEN1MAPT
SCHEMBL2568594 0.89 F10 (0.35) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2572138 0.89 MET (0.38) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2570115 0.89 F10 (0.35) WDR91KMT2ALMNAMAPK1MEN1
SCHEMBL2570785 0.89 KMT2A (0.43) WDR91KMT2ALMNAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP claimed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP claimed
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed